You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
上海力挺中醫藥創新發展 將重點培育一批龍頭藥企
阿思達克 05-26 08:22
上海發布《關於促進中醫藥傳承創新發展的實施意見》,從優化中醫藥服務體系、發揮中醫藥在健康服務中的獨特作用、發展中醫藥產業、促進中醫藥傳承和創新、推動中醫藥開放發展等方面,為中醫藥創新發展指明方向。

該意見提出,要優化中醫藥服務體系,包括推進中醫醫療資源提質擴容、實現基層中醫藥服務全覆蓋、創新中醫醫聯體建設模式。其中特別強調,支持社會力量舉辦具有特色優勢的中醫醫療機構,鼓勵連鎖經營。以信息化支撐中醫藥服務體系建設,大力發展互聯網中醫藥服務。

在發展中醫藥產業方面,該意見明確要從提升中藥產業發展水平。在提升中藥產業發展水平方面,重點培育和扶持一批現代化中藥龍頭企業和創新型企業,提高智能製造水平,助力打響「上海製造」品牌。

在助力中醫藥健康服務業發展方面,鼓勵社會力量舉辦規範的養生保健機構,培育一批技術成熟、服務規範、信譽良好的中醫養生保健集團或連鎖機構。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account